AI-Enhanced Minimally Invasive Devices Market Size is valued at US$ 5.7 Bn in 2024 and is predicted to reach US$ 27.8 Bn by the year 2034 at an 17.6% CAGR during the forecast period for 2025-2034.
The healthcare sector is undergoing a significant transformation as a result of the integration of artificial intelligence (AI) with minimally invasive tools. These instruments, which are designed to reduce physical intrusion during surgical or diagnostic procedures, offer benefits such as reduced recovery time and trauma. With AI, these devices have been transformed immensely by fostering enhanced accuracy, procedural effectiveness, and safety. Algorithms of AI are used to help with real-time imaging, navigation of the device, and decision-making intraoperatively, and these include examples such as robotic-assisted surgery systems, steerable catheters, and image-based AI imaging technologies. Market growth is highly robust and stimulated by the growing need for minimally invasive treatment procedures and relentless developments in technology.
Rapid tech advancement, a growing desire to use minimally invasive procedures, and the escalating incidence of cancer and cardiovascular conditions are some key drivers. Furthermore, higher R&D spending on AI-based medical technology is fueling innovation. Still, the industry also has significant restraints. Regulatory challenges may delay device clearances, and the expensive price of sophisticated systems such as surgery robots could curb access. Also, integration difficulties, technical talent shortages, and ethical issues relating to algorithmic bias pose consistent challenges. Yet, the industry has immense scope to transform current medical practices and patient care.
• Medtronic Plc
• Intuitive Surgical, Inc.
• Boston Scientific Corporation
• GE HealthCare
• Fujifilm Holdings Corporation
• Stryker Corporation
• Siemens Healthineers
• Johnson & Johnson (Ethicon + Auris Health)
• Olympus Corporation
• Zimmer Biomet
• Asensus Surgical, Inc.
• CMR Surgical
• Auris Health (J&J Subsidiary)
The AI-enhanced minimally invasive devices market is segmented by product type, application, end-user, and technology. By product type, the market is segmented into ai-enhanced catheters, ai-powered endoscopy systems, robotic-assisted surgical systems, imaging and visualization devices, and other devices. By application market is segmented into cardiology, gastroenterology, interventional radiology, orthopedics, urology and gynecology, others. By end user the market is segmented into hospitals, ambulatory surgical centers (ASCS), specialty clinics. By technology market is segmented into machine learning, computer vision, natural language processing (NLP), robotics.
Robotic-Assisted Surgical Systems are the most rapidly growing segment in the AI-powered minimally invasive devices market, due to their capacity to provide high precision, dexterity, and procedural efficiency in surgery. These systems utilize AI for real-time imaging and navigation, which is especially useful in complicated procedures like oncology and urology. Although AI-based endoscopy systems also hold promise through improved imaging and diagnostics, detailed growth data is scarce. Likewise, AI-powered catheters and imaging equipment have significant roles to play but are not yet being emphasized as key growth drivers. Of all the segments, robotic-assisted systems are notable for their sophisticated capabilities and increasing use across a variety of surgical specialties.
Urology and Gynecology segment is Growing at the Highest Rate in the AI-Enhanced Minimally Invasive Devices Market.
Urology and gynecology are experiencing high growth in the AI-powered minimally invasive devices market, fueled by technological advancements in robotic-assisted surgeries and AI-driven diagnostic imaging. In urology, the use of minimally invasive procedures for prostate cancer and BPH is increasing, with AI enhancing surgical accuracy, minimizing complications, and allowing personalized treatment planning through predictive analytics. In the same way, gynaecology is seeing the greater application of AI-enabled robotic systems in procedures such as hysterectomies, improving safety and accuracy. AI also enhances imaging and spatial perception, enabling surgeons to better identify critical structures and reduce risks while enabling personalized care through patient-specific data, ultimately enhancing clinical outcomes and patient satisfaction.
North America, especially the United States, dominates the market for minimally invasive devices augmented by artificial intelligence because of its advanced healthcare system, great acceptance of new technology, and strong legal environment. Extensive adoption of these technologies is driven by the region's top-notch medical facilities and strong culture of implementing ideas including robotic-assisted surgical systems and artificial intelligence-based imaging gadgets. Furthermore, North America's developed legal framework makes it simple to approve and use products enhanced by artificial intelligence. With a 4.1% increase, heavy healthcare expenditures—totaling $4.5 trillion in the United States in 2022—further support large investments in advanced medical technologies, therefore confirming the market leadership of the area.
|
Report Attribute |
Specifications |
|
Market Size Value In 2024 |
USD 5.7 Billion |
|
Revenue Forecast In 2034 |
USD 27.8 Billion |
|
Growth Rate CAGR |
CAGR of 17.6% from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Mn and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Product Type, Application, End-User, Technology and By Region |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
|
Competitive Landscape |
Medtronic Plc, Intuitive Surgical, Inc., Boston Scientific Corporation, GE HealthCare, Fujifilm Holdings Corporation, Stryker Corporation, Siemens Healthineers, Johnson & Johnson (Ethicon + Auris Health), Olympus Corporation, Zimmer Biomet, Asensus Surgical, Inc., CMR Surgical, Auris Health (J&J Subsidiary) |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global AI-Enhanced Minimally Invasive Devices Market Snapshot
Chapter 4. Global AI-Enhanced Minimally Invasive Devices Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2034
4.8. Competitive Landscape & Market Share Analysis, By Key Player (2024)
4.9. Use/impact of AI on AI-Enhanced Minimally Invasive Devices Market Industry Trends
4.10. Global AI-Enhanced Minimally Invasive Devices Market Penetration & Growth Prospect Mapping (US$ Mn), 2021-2034
Chapter 5. AI-Enhanced Minimally Invasive Devices Market Segmentation 1: By Product Type, Estimates & Trend Analysis
5.1. Market Share by Product Type, 2024 & 2034
5.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Product Type:
5.2.1. AI-Enhanced Catheters
5.2.2. AI-Powered Endoscopy Systems
5.2.3. Robotic-Assisted Surgical Systems
5.2.4. Imaging and Visualization Devices
5.2.5. Other Devices
Chapter 6. AI-Enhanced Minimally Invasive Devices Market Segmentation 2: By Application, Estimates & Trend Analysis
6.1. Market Share by Application, 2024 & 2034
6.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Application:
6.2.1. Cardiology
6.2.2. Gastroenterology
6.2.3. Interventional Radiology
6.2.4. Orthopedics
6.2.5. Urology and Gynecology
6.2.6. Others
Chapter 7. AI-Enhanced Minimally Invasive Devices Market Segmentation 3: By End User, Estimates & Trend Analysis
7.1. Market Share by End User, 2024 & 2034
7.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following End User:
7.2.1. Hospitals
7.2.2. Ambulatory Surgical Centers (ASCs)
7.2.3. Specialty Clinics
Chapter 8. AI-Enhanced Minimally Invasive Devices Market Segmentation 4: By Technology, Estimates & Trend Analysis
8.1. Market Share by Technology, 2024 & 2034
8.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Technology:
8.2.1. Machine Learning
8.2.2. Computer Vision
8.2.3. Natural Language Processing (NLP)
8.2.4. Robotics
Chapter 9. AI-Enhanced Minimally Invasive Devices Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. Global AI-Enhanced Minimally Invasive Devices Market, Regional Snapshot 2024 & 2034
9.2. North America
9.2.1. North America AI-Enhanced Minimally Invasive Devices Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.2.1.1. US
9.2.1.2. Canada
9.2.2. North America AI-Enhanced Minimally Invasive Devices Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
9.2.3. North America AI-Enhanced Minimally Invasive Devices Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.2.4. North America AI-Enhanced Minimally Invasive Devices Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
9.2.5. North America AI-Enhanced Minimally Invasive Devices Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
9.3. Europe
9.3.1. Europe AI-Enhanced Minimally Invasive Devices Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.3.1.1. Germany
9.3.1.2. U.K.
9.3.1.3. France
9.3.1.4. Italy
9.3.1.5. Spain
9.3.1.6. Rest of Europe
9.3.2. Europe AI-Enhanced Minimally Invasive Devices Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
9.3.3. Europe AI-Enhanced Minimally Invasive Devices Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.3.4. Europe AI-Enhanced Minimally Invasive Devices Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
9.3.5. Europe AI-Enhanced Minimally Invasive Devices Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
9.4. Asia Pacific
9.4.1. Asia Pacific AI-Enhanced Minimally Invasive Devices Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.4.1.1. India
9.4.1.2. China
9.4.1.3. Japan
9.4.1.4. Australia
9.4.1.5. South Korea
9.4.1.6. Southeast Asia
9.4.1.7. Rest of Asia Pacific
9.4.2. Asia Pacific AI-Enhanced Minimally Invasive Devices Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
9.4.3. Asia Pacific AI-Enhanced Minimally Invasive Devices Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.4.4. Asia Pacific AI-Enhanced Minimally Invasive Devices Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
9.4.5. Asia Pacific AI-Enhanced Minimally Invasive Devices Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
9.5. Latin America
9.5.1. Latin America AI-Enhanced Minimally Invasive Devices Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.5.1.1. Brazil
9.5.1.2. Mexico
9.5.1.3. Rest of Latin America
9.5.2. Latin America AI-Enhanced Minimally Invasive Devices Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
9.5.3. Latin America AI-Enhanced Minimally Invasive Devices Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.5.4. Latin America AI-Enhanced Minimally Invasive Devices Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
9.5.5. Latin America AI-Enhanced Minimally Invasive Devices Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
9.6. Middle East & Africa
9.6.1. Middle East & Africa Wind Turbine Rotor Blade Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.6.1.1. GCC Countries
9.6.1.2. South Africa
9.6.1.3. Rest of Middle East and Africa
9.6.2. Middle East & Africa AI-Enhanced Minimally Invasive Devices Market Revenue (US$ Million) Estimates and Forecasts by Product Type, 2021-2034
9.6.3. Middle East & Africa AI-Enhanced Minimally Invasive Devices Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
9.6.4. Middle East & Africa AI-Enhanced Minimally Invasive Devices Market Revenue (US$ Million) Estimates and Forecasts by End User, 2021-2034
9.6.5. Middle East & Africa AI-Enhanced Minimally Invasive Devices Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Medtronic Plc
10.2.1.1. Business Overview
10.2.1.2. Key Product Type/Service Overview
10.2.1.3. Financial Performance
10.2.1.4. Geographical Presence
10.2.1.5. Recent Developments with Business Strategy
10.2.2. Intuitive Surgical, Inc.
10.2.3. Boston Scientific Corporation
10.2.4. GE HealthCare
10.2.5. Fujifilm Holdings Corporation
10.2.6. Stryker Corporation
10.2.7. Siemens Healthineers
10.2.8. Johnson & Johnson (Ethicon + Auris Health)
10.2.9. Olympus Corporation
10.2.10. Zimmer Biomet
10.2.11. Asensus Surgical, Inc.
10.2.12. CMR Surgical
10.2.13. Auris Health (J&J Subsidiary)
AI-Enhanced Minimally Invasive Devices Market by Product Type-
• AI-Enhanced Catheters
• AI-Powered Endoscopy Systems
• Robotic-Assisted Surgical Systems
• Imaging and Visualization Devices
• Other Devices
AI-Enhanced Minimally Invasive Devices Market by Application -
• Cardiology
• Gastroenterology
• Interventional Radiology
• Orthopedics
• Urology and Gynecology
• Others
AI-Enhanced Minimally Invasive Devices Market by End User-
• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Specialty Clinics
AI-Enhanced Minimally Invasive Devices Market by Technology-
• Machine Learning
• Computer Vision
• Natural Language Processing (NLP)
• Robotics
AI-Enhanced Minimally Invasive Devices Market by Region-
North America-
• The US
• Canada
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Mexico
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
